Keller and Heckman Partner Azim Chowdhury will present at the Food and Drug Law Institute’s (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference, taking place virtually and in Washington, DC on October 20 – 21, 2022. Azim will serve as a panelist on the panel titled, “Novel Products and Future Innovation: How Would New
2022 National Youth Tobacco Survey Indicates Modest Increase in Youth Vaping Rates
- On October 6, 2022, FDA and CDC released data from the 2022 National Youth Tobacco Survey, a school-based, cross-sectional, self-administered survey of U.S. middle school (grades 6–8) and high school (grades 9–12) students. The study was conducted from January to May 2022. According to the survey, 14.1% of U.S. high school students and 3.3%
Counsel Daniel McGee to Present at Next Generation Nicotine Delivery USA 2022 Conference
Keller and Heckman Counsel Daniel McGee will present, “Navigating Evolving Vaping Laws Around the Country – State Law Update,” at the Next Generation Nicotine Delivery USA 2022 event, June 22-23, 2022, in Miami, Florida. This event will bring together business leaders from the ENDS and tobacco industry together with other experts in the field for
FDA Issues Delta-8 THC Warning Letters
Reposted from Keller and Heckman’s Blog, The Daily Intake
- On May 4, 2022, FDA announced that it had issued warning letters to five companies selling products (including gummies, capsules, tinctures, lotions, vaping products, pet products, and hand sanitizers) labeled as containing delta-8 tetrahydrocannabinol (delta-8 THC), as well as cannabidiol (CBD), in violation of the Federal
Watch it Now – Keller and Heckman’s E-Vapor and Tobacco Law Symposium
In case you couldn’t attend our recently held “E-Vapor and Tobacco Law Symposium” we recorded it—so you can view it at your leisure. Register today and receive full access to the recorded sessions, along with seminar presentations and other materials.
Keller and Heckman is pleased to provide on-demand access to our two-day comprehensive seminar focused
Keller and Heckman Associate Neelam Gill to Participate in Panel on Tobacco Standards at FDLI Conference
Keller and Heckman Associate Neelam Gill will be a panelist at the Food and Drug Law Institute’s (FDLI) Enforcement, Litigation, and Compliance Conference, to be held virtually on December 9 – 10, 2021. Neelam will be participating in the panel on “Preparing for Tobacco Product Standards and cGMPs,” which will focus on pending Tobacco Product
Registration is Now Open for Keller and Heckman’s Annual E-Vapor and Tobacco Law Symposium
Please be sure to join us for a two-day comprehensive seminar focused on legal and regulatory issues critical to e-vapor, tobacco, and CBD industries following the aftermath of FDA’s decisions on millions of premarket applications. Topics that will be covered include PMTA marketing denial order (MDO) challenges, new requirements for PMTAs and Substantial Equivalence reports,
Neelam Gill to Present at Next Generation Nicotine Delivery USA 2021
Keller and Heckman Associate Neelam Gill will present, “Remote Regulatory Assessments for Vapor Product Manufacturers in PMTA Review: What to Expect and How to Prepare,” at the Next Generation Nicotine Delivery USA 2021 event, June 9, 2021. This virtual event will bring together business leaders from the ENDS and tobacco industry together with other experts
FDA Issues Warning Letters to Vape Companies that Did Not Submit Premarket Tobacco Product Applications (PMTAs)
Reposted from Keller and Heckman’s Blog, The Daily Intake
- On January 15, 2021, the U.S. Food and Drug Administration (FDA) issued warning lettersto ten companies that sell electronic nicotine delivery system (ENDS) products, including e-liquids. FDA’s letters warned that any new tobacco product not in compliance with the premarket authorization requirements of the Federal
Agenda and Speakers Announced: 2021 E-Vapor and Tobacco Law Symposium
Keller and Heckman is pleased to announce the agenda for our 5th Annual E-Vapor and Tobacco Law Symposium.
This year’s virtual program will feature new, timely topics specifically designed to help vapor and deemed tobacco product manufacturers stay in compliance with rapidly evolving laws and policies. Topics that will be discussed include:
- FDA’s new guidance